SONN - Sonoma Pharmaceuticals files for offering of 5M shares
2023-09-20 09:21:37 ET
More on Sonnet BioTherapeutics
- Seeking Alpha’s Quant Rating on Sonnet BioTherapeutics
- Historical earnings data for Sonnet BioTherapeutics
- Financial information for Sonnet BioTherapeutics
- Sonnet BioTherapeutics stock plummets 20% on $2.25M registered direct offering
For further details see:
Sonoma Pharmaceuticals files for offering of 5M shares